bpc 157 clinical trial ulcer Frontiers BPC-157 - Peptide for Gut

Description

in 2005 [37]

1 - 13 The data so far presented suggested that BPC 157 may modulate NO-system effect, providing that its effectiveness could override the effects of NOS-blockade (induced by NOS-blocker L-NAME), NOS-overstimulation (induced by NOS-substrate L-arginine application), or NOS-system immobilization (induced by simultaneous administration of L-NAME and L-arginine)

Antibody-mediated selective targeting of CD38 thus represents a promising therapeutic strategy for SSc and related fibroinflammatory conditions currently lacking effective treatment

The use of the BPC peptide salt according to any one of claims 1 to 9 for the preparation of a storage-stable pharmaceutical composition according to claim 10 as a cyto-protective and organo-protective agent